Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.43M | $ 18.51M | $ 12.40M | $ 8.40M | $ 5.43M |
| Gross Profit | $ 25.33M | $ 15.91M | $ 10.14M | $ 7.21M | $ 3.24M |
| Operating Income | $ -36.16M | $ -54.15M | $ -36.44M | $ -24.03M | $ -108.49K |
| EBITDA | $ -36.16M | $ -58.30M | $ -46.76M | $ -23.57M | $ -25.32M |
| Net Income | $ -33.23M | $ -59.04M | $ -47.19M | $ -28.84M | $ -31.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.53M | $ 11.78M | $ 9.41M | $ 30.30M | $ 4.49M |
| Total Assets | $ 23.97M | $ 25.73M | $ 22.00M | $ 37.84M | $ 252.01M |
| Total Debt | $ 23.63M | $ 1.59M | $ 1.96M | $ 544.00K | $ 42.18M |
| Net Debt | $ 15.10M | $ -10.18M | $ -7.45M | $ -29.76M | $ 40.85M |
| Total Liabilities | $ 49.87M | $ 51.66M | $ 198.32M | $ 167.44M | $ 23.50M |
| Stockholders' Equity | $ -25.89M | $ -25.94M | $ -176.33M | $ 30.90M | $ 228.52M |
| Cash Flow | |||||
| Free Cash Flow | $ -41.19M | $ -51.17M | $ -33.10M | $ -23.95M | $ -1.22M |
| Operating Cash Flow | $ -40.84M | $ -50.58M | $ -32.31M | $ -22.70M | $ -677.60K |
| Investing Cash Flow | $ -345.00K | $ -2.12M | $ -1.79M | $ -2.26M | $ -250.00M |
| Financing Cash Flow | $ 37.94M | $ 54.63M | $ 13.46M | $ 50.77M | $ 252.01M |